[Federal Register Volume 75, Number 182 (Tuesday, September 21, 2010)]
[Notices]
[Pages 57473-57474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-23545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 57474]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, T32 Review.
    Date: September 21, 2010.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Sergei Radaev, PhD, Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8113, Bethesda, MD 20892. 301-435-5655. 
<a href="/cdn-cgi/l/email-protection#d4a7a6b5b0b5b1a294b9b5bdb8fababdbcfab3bba2"><span class="__cf_email__" data-cfemail="5122233035303427113c30383d7f3f38397f363e27">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Preclinical Toxicology Study of Drugs Developed for Cancer 
and Other Diseases.
    Date: September 23, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review 
Officer, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8055A, MSC 8329, Bethesda, MD 20852. 
<a href="/cdn-cgi/l/email-protection#c7bda8b2bdafaeb687aaa6aeabe9a9aeafe9a0a8b1"><span class="__cf_email__" data-cfemail="502a3f252a383921103d31393c7e3e39387e373f26">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to scheduling conflicts.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Therapeutic Strategies for Cancer.
    Date: October 14-15, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Majed M. Hamawy, MBA, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8135, Bethesda, MD 20852. 301-594-5659. 
<a href="/cdn-cgi/l/email-protection#ff9297cecfce89bf919697d1989089"><span class="__cf_email__" data-cfemail="412c2970717037012f28296f262e37">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Cellular & Tissue Biology II P01.
    Date: October 19, 2010.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8018, Rockville, MD 20852. (Telephone Conference Call.)
    Contact Person: Caron A. Lyman, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Blvd, Room 8119, Bethesda, 
MD 20892-8328. 301-451-4761. <a href="/cdn-cgi/l/email-protection#335f4a5e525d50735e525a5f1d5d5a5b1d545c45"><span class="__cf_email__" data-cfemail="9ef2e7f3fff0fddef3fff7f2b0f0f7f6b0f9f1e8">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Small Grants Program for Cancer Epidemiology.
    Date: October 28-29, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Joyce C. Pegues, BS, BA, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7149, Bethesda, MD 20892-8329. 301-594-1286. 
<a href="/cdn-cgi/l/email-protection#98e8fdffedfdebf2d8f5f9f1f4b6f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="f9899c9e8c9c8a93b994989095d7979091d79e968f">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Small Grants Behavioral Research in Cancer Control.
    Date: November 15-16, 2010.
    Time: 7 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Gerald G. Lovinger, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8101, Bethesda, MD 20892-8329. 301/496-7987. 
<a href="/cdn-cgi/l/email-protection#ea86859c83848d8f8daa878b8386c4848382c48d859c"><span class="__cf_email__" data-cfemail="600c0f16090e070507200d01090c4e0e09084e070f16">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 15, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-23545 Filed 9-20-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>